HUE032956T2 - Bevonattal ellátott részecskék és gyógyászati dózisformák - Google Patents

Bevonattal ellátott részecskék és gyógyászati dózisformák

Info

Publication number
HUE032956T2
HUE032956T2 HUE04710142A HUE04710142A HUE032956T2 HU E032956 T2 HUE032956 T2 HU E032956T2 HU E04710142 A HUE04710142 A HU E04710142A HU E04710142 A HUE04710142 A HU E04710142A HU E032956 T2 HUE032956 T2 HU E032956T2
Authority
HU
Hungary
Prior art keywords
dosage forms
pharmaceutical dosage
coated particles
particles
coated
Prior art date
Application number
HUE04710142A
Other languages
English (en)
Inventor
Vlasta Humar
Mateja Burjak
Rok Grahek
Mateja Salobir
Janez Kerc
Klemen Kocevar
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of HUE032956T2 publication Critical patent/HUE032956T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE04710142A 2003-02-12 2004-02-11 Bevonattal ellátott részecskék és gyógyászati dózisformák HUE032956T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300041A SI21402A (sl) 2003-02-12 2003-02-12 Obloženi delci in farmacevtske oblike

Publications (1)

Publication Number Publication Date
HUE032956T2 true HUE032956T2 (hu) 2017-11-28

Family

ID=32867327

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE04710142A HUE032956T2 (hu) 2003-02-12 2004-02-11 Bevonattal ellátott részecskék és gyógyászati dózisformák

Country Status (10)

Country Link
US (3) US20060093680A1 (hu)
EP (1) EP1594474B1 (hu)
AU (2) AU2004211887A1 (hu)
BR (1) BRPI0407474A (hu)
CA (1) CA2514720C (hu)
ES (1) ES2636537T3 (hu)
HU (1) HUE032956T2 (hu)
SI (1) SI21402A (hu)
WO (1) WO2004071403A2 (hu)
ZA (1) ZA200506240B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
CA2383522C (en) * 1999-08-16 2011-12-06 Revaax Pharmaceuticals, Llc Neurotherapeutic composition and method
UA78326C2 (uk) * 2002-06-12 2007-03-15 Сінгента Партісіпейшнс Аг Гербіцидна синергетична композиція та спосіб боротьби з ростом небажаної рослинності
WO2005004989A2 (en) * 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
MY147202A (en) * 2003-11-26 2012-11-14 Novartis Ag Compositions comprising organic compounds
CA2588216A1 (en) 2004-11-22 2006-05-26 Dexcel Pharma Technologies Ltd. Stable atorvastatin formulations
US20060229277A1 (en) * 2005-04-08 2006-10-12 Orbus Pharma, Inc. Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
DK1944029T3 (da) * 2005-10-31 2012-01-23 Kowa Co Farmaceutisk præparat med fremragende fotostabilitet
CN101330919B (zh) * 2005-12-20 2012-12-05 力奇制药公司 包含(e)-7-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰基)氨基]嘧啶-5-基]-(3r,5s)-3,5-二羟基庚-6-烯酸的药物组合物
EP1818049A3 (en) 2006-02-10 2008-11-19 LifeCycle Pharma A/S Stabilized Atorvastatin
CN101091725A (zh) * 2006-06-23 2007-12-26 天津天士力制药股份有限公司 一种中药颗粒及其制备方法
EP2100606A4 (en) * 2006-12-07 2009-12-30 Daiichi Sankyo Co Ltd COATED PREPARATION OF A FILM HAVING IMPROVED STABILITY
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
KR100805208B1 (ko) * 2007-03-27 2008-02-21 주식회사 펩트론 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법
JP2011500811A (ja) * 2007-10-26 2011-01-06 レクサン ファーマシューティカルズ インコーポレイテッド クラブラン酸の医薬品製剤
EP2070520A1 (en) 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
ES2817504T3 (es) * 2008-01-25 2021-04-07 Laboratoires Majorelle Combinaciones de medicamentos orales aglutinados por una envoltura
US20110038933A1 (en) * 2008-05-06 2011-02-17 Dexcell Ltd. Stable benzimidazole formulation
WO2009140341A2 (en) * 2008-05-13 2009-11-19 Dr. Reddy's Laboratories Ltd. Atorvastatin compositions
CA2637977A1 (en) * 2008-07-15 2010-01-15 Pharmascience Inc. Dosage form containing a statin
AU2010242948A1 (en) * 2009-04-29 2011-11-24 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
US20110104277A1 (en) * 2009-10-30 2011-05-05 Ma Decheng Oxygen barrier film coatings for pharmaceutical dosage forms
WO2011077843A1 (ja) * 2009-12-25 2011-06-30 沢井製薬株式会社 アトルバスタチン含有被覆製剤
US9795576B2 (en) * 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
CA2868187A1 (en) * 2012-03-26 2013-10-03 The Regents Of The University Of California Aerosol coating process based on volatile, non-flammable solvents
TWI636783B (zh) * 2012-04-18 2018-10-01 友霖生技醫藥股份有限公司 含匹伐他汀（ｐｉｔａｖａｓｔａｔｉｎ）穩定配方的醫藥組合物
EP3106152B1 (en) * 2014-02-12 2021-02-17 Sawai Pharmaceutical Co., Ltd. Orally disintegrating tablet coated with film
JP6737793B2 (ja) * 2015-01-29 2020-08-12 ノヴォ ノルディスク アー／エス 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN107485605A (zh) * 2017-08-02 2017-12-19 南京泽恒医药技术开发有限公司 一种磺胺嘧啶银喷膜剂及其制备方法
WO2019161402A1 (en) * 2018-02-19 2019-08-22 Sensient Colors Llc Compositions for coating edible substrates and methods of making and using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816061A (en) * 1954-05-27 1957-12-10 Univ Illinois Sodium carboxymethyl cellulose tablet coating
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4428926A (en) 1981-12-18 1984-01-31 Key Pharmaceuticals, Inc. Sustained release propranolol system
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
DE69232290T2 (de) 1991-10-07 2002-06-13 Genencor Int Umhüllte enzym enthaltende körnchen
CN1097619C (zh) * 1994-07-12 2003-01-01 伯温德药品服务公司 隔潮膜涂层组合物及其生产方法以及涂层制品
US5573783A (en) * 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
JP2000516222A (ja) * 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング 嚥下が容易な経口医薬組成物
JP2001501207A (ja) 1996-09-24 2001-01-30 イーライ・リリー・アンド・カンパニー コーティングされた粒子製剤
NZ520176A (en) 1997-07-31 2005-02-25 Kos Life Sciences Inc Combinations of HMG-CoA reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night
EP1035834B1 (en) * 1997-12-05 2002-04-17 Alza Corporation Osmotic dosage form comprising first and second coats
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
CA2360655C (en) 1999-01-29 2007-03-20 Losan Pharma Gmbh Pharmaceutical compositions
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
SE9902386D0 (sv) 1999-06-22 1999-06-22 Astra Ab New formulation
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
US20020086061A1 (en) * 1999-10-26 2002-07-04 Sharma Vinay K. Preparation of micron-size felodipine particles by microfluidization
JP2003523948A (ja) 1999-11-04 2003-08-12 アンドルクス コーポレーション アミロイドβ前駆体障害の治療法
WO2001037876A2 (en) 1999-11-24 2001-05-31 Bayer Aktiengesellschaft Methods of ameliorating abnormal bone states
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US20030018040A1 (en) 2000-02-10 2003-01-23 Yasuo Sugiyama Tnf-alpha inhibitors
US7081240B1 (en) 2000-06-28 2006-07-25 Zimmer Orthobiologics, Inc. Protein mixtures for wound healing
AU2001284772A1 (en) * 2000-08-10 2002-02-25 Delsys Pharmaceutical Corporation Improved solid pharmaceutical dosage formulation of hydrophobic drugs
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
SI20848A (sl) * 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Farmacevtska formulacija, ki vsebuje atorvastatin kalcij
US7642286B2 (en) * 2001-06-21 2010-01-05 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions containing pravastatin
GB2401547B (en) * 2003-05-08 2005-07-20 Nektar Therapeutics Uk Ltd Particulate materials

Also Published As

Publication number Publication date
SI21402A (sl) 2004-08-31
WO2004071403A3 (en) 2005-02-24
EP1594474A2 (en) 2005-11-16
ZA200506240B (en) 2007-02-28
BRPI0407474A (pt) 2006-02-07
EP1594474B1 (en) 2017-03-22
US9149460B2 (en) 2015-10-06
CA2514720C (en) 2013-05-14
CA2514720A1 (en) 2004-08-26
AU2004211887A1 (en) 2004-08-26
US20160128946A1 (en) 2016-05-12
WO2004071403A2 (en) 2004-08-26
AU2011201400A1 (en) 2011-04-14
US20080138429A1 (en) 2008-06-12
US20060093680A1 (en) 2006-05-04
AU2011201400B2 (en) 2011-06-23
US9907757B2 (en) 2018-03-06
ES2636537T3 (es) 2017-10-06

Similar Documents

Publication Publication Date Title
ZA200506240B (en) Coated particles and pharmaceutical dosage forms
HK1072559A1 (en) Methods and dosage forms for controled delivery ofpaliperidone
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
PL400027A1 (pl) Wieloelementowa farmaceutyczna postac dawkowania i sposób jej wytwarzania
IL169112A (en) Phosphonooxy quinazoline derivatives and their pharmaceutical use
EP1539129A4 (en) DOSAGE FORMS AND RELEVANT THERAPIES
AU2003266133A8 (en) Materials and methods for drug delivery and uptake
HK1078086A1 (zh) 雜芳族五環化合物及其醫藥用途
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
IL178067A0 (en) Pharmaceutical dosage forms and compositions
PL359321A1 (en) New salt perindopryl and pharmaceutical composunds containing it
EP1585500A4 (en) COATED PARTICLES INTENDED FOR THE PROLONGED DELIVERY OF PHARMACEUTICAL INGREDIENTS
EP1658105A4 (en) AEROSOL-PHARMACEUTICAL DOSER AND ASSOCIATED METHODS
SG116507A1 (en) Pharmaceutical dosage form and method of making.
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
IL179669A0 (en) Benzoimidazole derivatives and pharmaceutical compositions containing the same
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
PT1849468E (pt) Composição farmacêutica compreendendo roflumilaste levocetirizina
EP1654312A4 (en) PHARMACEUTICAL DOSING INHALER AND RELATED METHODS
HK1094153A1 (en) Nasal pharmaceutical composition of piribedil
EP1653953A4 (en) METHOD AND DEVICES FOR THE MEDICINAL PRODUCTION
GB0214751D0 (en) Particle size reduction of poorly soluble drugs